Martin Duvall

Martin J.
Duvall is currently Chairman at Oncopeptides, Inc., Director at Oncopeptides Incentive AB, and Senior Vice President-Commercial Operations at MGI PHARMA Biologics, Inc. Former roles include Chief Executive Officer & Director at Tocagen, Inc. (2016–2020), Chief Executive Officer at Oncopeptides AB (2020–2021), Senior Vice President & General Manager at Merck & Co., Inc. (2010–2011), Senior Vice President-Commercial Operations at MGI PHARMA, Inc. (2004–2011), Chief Commercial Officer & Executive VP at ARIAD Pharmaceuticals, Inc. (2015–2016), Senior Vice President-Global Marketing at Abraxis BioScience, Inc. (2009–2011), and Vice President at Aventis Pharmaceuticals, Inc. Education includes graduate studies at The Johns Hopkins University, undergraduate studies at Muhlenberg College, and an MBA from the University of Kansas.